Dementia D003704

Psychiatry and Psychology [F] » Mental Disorders [F03] » Neurocognitive Disorders » Dementia

Description

An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.   MeSH

Hierarchy View

Subtype Terms (10)

AIDS Dementia Complex
18 drugs (15 approved, 3 experimental)

Alzheimer Disease
611 drugs (193 approved, 418 experimental)

Aphasia, Primary Progressive
4 drugs (2 approved, 2 experimental)

Creutzfeldt-Jakob Syndrome
1 experimental drug

Dementia, Vascular
45 drugs (26 approved, 19 experimental)

Diffuse Neurofibrillary Tangles with Calcification
 

Frontotemporal Lobar Degeneration
3 approved drugs

Huntington Disease
83 drugs (42 approved, 41 experimental)

Kluver-Bucy Syndrome
 

Lewy Body Disease
36 drugs (19 approved, 17 experimental)


Phase 3 Indicated Drugs (85)


Organization Involved with Phase 3 Indications (87)

Organization Involved with Phase 2 Indications (108)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.